(Q34326941)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11486896%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

review article

1 reference

title

Management of neuronopathic Gaucher disease: a European consensus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11486896%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11486896%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

A Vellodi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11486896%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

B Bembi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11486896%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

T B de Villemeur

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11486896%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

T Collin-Histed

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11486896%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A Erikson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11486896%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

E Mengel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11486896%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A Rolfs

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11486896%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Neuronopathic Gaucher Disease Task Force of the European Working Group on Gaucher Disease

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11486896%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 June 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11486896%20AND%20SRC:MED&resulttype=core&format=json

Journal of Inherited Metabolic Disease

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11486896%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11486896%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11486896%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

319-327

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11486896%20AND%20SRC:MED&resulttype=core&format=json

Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease.

10 November 2019

cites work

1 reference

12 December 2020

Pathological findings in Gaucher disease type 2 patients following enzyme therapy

1 reference

12 December 2020

Gaucher disease--Norrbottnian type (III). Neuropaediatric and neurobiological aspects of clinical patterns and treatment

1 reference

12 December 2020

Types I and III Gaucher disease in Poland: incidence of the most common mutations and phenotypic manifestations

1 reference

12 December 2020

Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotype

1 reference

12 December 2020

Ten years' experience of bone marrow transplantation for Gaucher disease.

1 reference

12 December 2020

Clinical and genetic studies of Japanese homozygotes for the Gaucher disease L444P mutation

1 reference

12 December 2020

Isolated horizontal supranuclear gaze palsy as a marker of severe systemic involvement in Gaucher's disease.

1 reference

12 December 2020

Changes in serum chitotriosidase activity with cessation of replacement enzyme (cerebrosidase) administration in Gaucher disease

1 reference

12 December 2020

Rapidly progressive type III Gaucher disease: deterioration following partial splenectomy.

1 reference

12 December 2020

Enzyme replacement therapy of infantile Gaucher disease

1 reference

12 December 2020

Prediction of severity of Gaucher's disease by identification of mutations at DNA level

1 reference

12 December 2020

Ocular motor abnormalities in Gaucher disease

1 reference

12 December 2020

New Gaucher disease mutations in exon 10: a novel L444R mutation produces a new NciI site the same as L444P

1 reference

12 December 2020

Ethical considerations for enzyme replacement therapy in neuronopathic Gaucher disease.

1 reference

12 December 2020

Gaucher disease: enzyme therapy in the acute neuronopathic variant

1 reference

12 December 2020

Neuronopathic forms of Gaucher's disease

1 reference

12 December 2020